DBJ Capital Co., Ltd., established in June 2010, is a corporate venture capital investment arm of the Development Bank of Japan, located in Tokyo. The firm emerged from the integration of two venture capital entities within the DBJ Group. DBJ Capital focuses on investing in companies that leverage new technologies and innovative business models across various industries to enhance their competitive edge in the global market. The company offers tailored investment solutions, including equity investments and financing options, utilizing the extensive resources of the DBJ Group. In addition to capital investment, DBJ Capital provides hands-on support to help startups commercialize their intellectual property and technologies developed by firms, research labs, and universities. By fostering the growth of the companies it invests in, DBJ Capital aims to contribute to Japan's economic revival and stimulate the creation of new industries within the country.
ShareDine operates an online platform that provides nutritional guidance and cooking experiences, founded in 2017 and based in Minato, Japan. The company offers a subscription service that connects users with traveling chefs who specialize in various dietary needs, including nutrition for pregnancy, postpartum care, baby food, and lifestyle-related diseases such as diabetes. ShareDine's chefs, approximately 1,600 in total, possess credentials as registered dietitians and cooking professionals, with experience in diverse settings like hospitals, nursery schools, hotels, and restaurants. The service includes corporate wellness offerings, meal seminars, and personalized cooking assistance, allowing users to receive tailored culinary support based on their individual preferences and health requirements. By facilitating access to expert chefs, ShareDine aims to enhance the dining experience for families, individuals, and various lifestyle groups.
REJECT
Series B in 2024
REJECT is an esports and entertainment organization that specializes in the management and operation of professional esports teams. Founded in 2018 and based in Minato, Japan, REJECT focuses on fostering communication and creativity within the esports community. The organization provides comprehensive team management services, which include the planning and execution of campaigns, events, and exhibitions. By combining esports with cultural elements, REJECT aims to enhance the domestic esports market and elevate players to national prominence, bridging gaps across various demographics and fostering inclusivity.
Kakeai
Series B in 2024
KAKEAI, Inc. is a Tokyo-based company founded in 2018 that specializes in developing an AI cloud system designed to enhance member management, particularly within middle management. Its platform aims to eliminate misunderstandings regarding member characteristics and situations, allowing organizations to utilize management knowledge effectively across all levels. By improving communication, productivity, collaboration, and employee engagement, KAKEAI's solution creates a conducive working environment, helping employees achieve greater job satisfaction. The company's focus is on providing tools that enable organizations to better understand and manage their workforce dynamics.
nearMe
Series C in 2024
NearMe Inc. is a Tokyo-based company that specializes in a mobile application designed for taxi ride-sharing services. Founded in 2017, the application facilitates instant matching of individuals traveling in the same direction, addressing inefficiencies in transportation and commuting. By enabling users to share taxi rides in real time, NearMe aims to improve the commuting experience and promote a more sustainable community. The platform addresses social inefficiencies by connecting users with similar travel interests, ultimately contributing to a more comfortable and efficient commuting solution.
Cellusion
Series C in 2023
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.
Kyoto Fusioneering
Series C in 2023
Kyoto Fusioneering is a privately funded technology start-up established in 2019 and based in Kyoto, Japan. The company specializes in developing advanced technologies for commercial fusion reactors, including gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. By providing innovative solutions such as liquid metal and molten salt systems, as well as tritium treatment and high-frequency microwave gyrotrons, Kyoto Fusioneering aims to support both public and private fusion developers globally. The company's efforts contribute to the acceleration of fusion energy as a sustainable and carbon-free power source for the future.
Wakaze
Series B in 2023
Wakaze Inc. specializes in the development and manufacturing of Japanese sake, offering a variety of products including craft sake, beer, and other alcoholic beverages. Founded in 2016 and based in Tsuruoka, Japan, with an additional office in Tokyo, the company markets its sake under the brands ORBIA, which includes SOL and LUNA, and FONIA, featuring SORRA and TERRA. Wakaze aims to provide high-quality sake at affordable prices, utilizing methods such as oak barrel aging and the incorporation of botanical ingredients and tea leaves in their brewing process. The company's products are available for online purchase, and it also offers a concierge service for sake, enhancing the consumer experience.
Techtouch
Series B in 2023
Techtouch, Inc. is a Tokyo-based company founded in 2018 that specializes in developing TechTouch, a digital transformation platform designed to improve operational efficiency for businesses. Its software provides an intuitive website user manual by overlaying explanatory guidance directly onto existing web systems through a browser plug-in and server-side integration. This approach allows for real-time navigation assistance, minimizing the challenges associated with complex system operations. By enhancing system education for employees and promoting better utilization of web resources, Techtouch aims to reduce operational burdens and streamline business processes.
ShareDine
Series A in 2022
ShareDine operates an online platform that provides nutritional guidance and cooking experiences, founded in 2017 and based in Minato, Japan. The company offers a subscription service that connects users with traveling chefs who specialize in various dietary needs, including nutrition for pregnancy, postpartum care, baby food, and lifestyle-related diseases such as diabetes. ShareDine's chefs, approximately 1,600 in total, possess credentials as registered dietitians and cooking professionals, with experience in diverse settings like hospitals, nursery schools, hotels, and restaurants. The service includes corporate wellness offerings, meal seminars, and personalized cooking assistance, allowing users to receive tailored culinary support based on their individual preferences and health requirements. By facilitating access to expert chefs, ShareDine aims to enhance the dining experience for families, individuals, and various lifestyle groups.
Spacely
Venture Round in 2022
Spacely, Inc. is a cloud software company based in Tokyo, Japan, that specializes in the creation and editing of virtual reality (VR) content. Founded in 2013 and previously known as 3D Stylee until its rebranding in 2018, Spacely offers an intuitive platform that allows users to manage VR web content using photos captured with 360-degree cameras. The software caters to various industries, including real estate, tourism, and retail, enabling businesses to develop their own VR services through an application programming interface (API). By simplifying the VR content creation process, Spacely aims to provide a seamless experience for users looking to engage audiences through immersive digital experiences.
Kyoto Fusioneering
Series B in 2022
Kyoto Fusioneering is a privately funded technology start-up established in 2019 and based in Kyoto, Japan. The company specializes in developing advanced technologies for commercial fusion reactors, including gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. By providing innovative solutions such as liquid metal and molten salt systems, as well as tritium treatment and high-frequency microwave gyrotrons, Kyoto Fusioneering aims to support both public and private fusion developers globally. The company's efforts contribute to the acceleration of fusion energy as a sustainable and carbon-free power source for the future.
Cellusion
Venture Round in 2022
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.
Sprocket
Series C in 2021
Sprocket Inc., founded in 2014 and based in Tokyo, Japan, specializes in developing customer development applications. The company offers a web-based platform that enhances customer service by optimizing conversion rates through the analysis of user behavior. Sprocket's solution allows businesses to implement a continuous improvement cycle by formulating hypotheses, conducting tests, and evaluating results based on key performance indicators and goals. Its tools are designed to foster long-term relationships between companies and their end users, improving the overall customer experience across various industries. The platform is compatible with both Android and iOS, making it accessible to a wide range of users.
Kyulux
Series B in 2021
Kyulux, Inc. is a Japanese company specializing in the research and development of organic electroluminescent materials for organic light-emitting diode (OLED) displays and lighting solutions. Founded in 2015 and based in Fukuoka, Kyulux is a leader in the advancement of thermally activated delayed fluorescence (TADF) technology, which enhances the efficiency of OLED emission. The company offers innovative products, including its proprietary Hyperfluorescence solution, which combines TADF and fluorescence emitters. This technology enables manufacturers in the display and lighting industries to produce cost-effective, durable, and efficient OLED solutions without relying on rare metals. With a significant intellectual property portfolio developed at Kyushu University and in collaboration with industrial partners, Kyulux is positioned at the forefront of the OLED technology market.
nearMe
Series A in 2020
NearMe Inc. is a Tokyo-based company that specializes in a mobile application designed for taxi ride-sharing services. Founded in 2017, the application facilitates instant matching of individuals traveling in the same direction, addressing inefficiencies in transportation and commuting. By enabling users to share taxi rides in real time, NearMe aims to improve the commuting experience and promote a more sustainable community. The platform addresses social inefficiencies by connecting users with similar travel interests, ultimately contributing to a more comfortable and efficient commuting solution.
Aiforce Solutions
Venture Round in 2020
Aiforce Solutions Inc. specializes in artificial intelligence-based democratization solutions, offering a range of services designed to improve business operations through AI. Founded in 2018 and headquartered in Tokyo, Japan, with operations in Ho Chi Minh City, Vietnam, the company provides tools and services that enable non-experts to build and implement AI models with ease. Their flagship products include AMATERAS RAY, which assists businesses like ice cream chains and automobile manufacturers in demand forecasting, and AMATERAS EDU, an AI education service tailored for business applications. Additionally, Aiforce Solutions offers AI Development Due Diligence and AI Implementation Consulting, which help clients reform their businesses and develop prototypes at competitive costs. The company's focus is on facilitating the use of AI across various industries, enhancing accuracy, work efficiency, and cost-effectiveness for its clients.
Alivas
Series A in 2020
Alivas Inc. is a medical company based in Hongo, Tokyo, Japan, that specializes in developing therapeutic medical devices aimed at treating refractory constipation. Founded in 2017, Alivas emerged as a joint venture between Stanford University and the University of Tokyo, leveraging the Japan Biodesign program to foster innovative solutions in medical device creation. The company's primary focus is on addressing intractable chronic constipation, providing patients with effective treatment options to alleviate their condition and improve their quality of life.
Techtouch
Series A in 2020
Techtouch, Inc. is a Tokyo-based company founded in 2018 that specializes in developing TechTouch, a digital transformation platform designed to improve operational efficiency for businesses. Its software provides an intuitive website user manual by overlaying explanatory guidance directly onto existing web systems through a browser plug-in and server-side integration. This approach allows for real-time navigation assistance, minimizing the challenges associated with complex system operations. By enhancing system education for employees and promoting better utilization of web resources, Techtouch aims to reduce operational burdens and streamline business processes.
Photoruction
Venture Round in 2020
Photoruction, Inc. is a Tokyo-based company that specializes in providing internet services tailored for the construction industry. Founded in 2016, Photoruction offers a cloud platform designed for construction photography and civil engineering support. Its flagship product facilitates the documentation of construction processes through an app that allows architects, construction teams, and landowners to capture, save, and share blueprints and photographs. The platform digitizes traditionally paper-based workflows, automates the organization of albums and photos, and enhances data sharing capabilities. Additionally, Photoruction develops an AI-driven engine that interprets information from drawings and photographs, aiming to streamline various phases of construction projects, from design to procurement. This technology enables clients to significantly reduce operational time and enhance productivity.
TVISION INSIGHTS
Venture Round in 2020
TVISION INSIGHTS Co. Ltd. is a Tokyo-based company that specializes in media research for television, focusing on measuring and analyzing the effects of TV commercials and programs. Established in 2015, the company employs advanced human body recognition technology to assess "viewing quality," capturing unique data on TV viewing habits in living rooms. This innovative approach allows TVISION to collect and analyze information that is not readily available elsewhere, creating a distinctive data set. The company has expanded its operations globally, with additional offices in Boston and New York, and continues to grow rapidly by addressing challenges in various markets while striving to unlock the full potential of television.
Ginco
Series A in 2020
Ginco Inc. is a Tokyo-based company established in 2017 that specializes in blockchain technology and cryptocurrency solutions. Its primary product is the Ginco mobile cryptocurrency wallet, which enables users to manage various digital assets securely through multi-signature technology. The wallet supports multiple cryptocurrencies, including Bitcoin, Ethereum, and Ripple, and is designed to accommodate both hot and cold wallet functionalities. In addition to its wallet services, Ginco offers crypto mining, enterprise wallet solutions, and node management services. The company's mission is to reshape the relationship between individuals and their assets by leveraging blockchain technology, with plans to expand into decentralized exchanges and other facets of the evolving digital currency ecosystem.
Kringle Pharma
Venture Round in 2020
Kringle Pharma, Inc. is a biopharmaceutical company based in Ibaraki, Japan, founded in 2001. The company focuses on the research and development of hepatocyte growth factor (HGF) and its applications in treating various medical conditions. Kringle Pharma's HGF products aim to promote regenerative healing in liver cells and other organs, addressing acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scars. Additionally, the company develops NK4, a bi-functional molecule that serves as an HGF antagonist, inhibiting tumor cell invasion and metastasis while exhibiting antiangiogenic properties. Kringle Pharma's pipeline includes recombinant human HGF for acute renal failure and skin ulcers, as well as NK4-based therapies for cancer treatment.
Cellusion
Series A in 2020
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.
nearMe
Series A in 2019
NearMe Inc. is a Tokyo-based company that specializes in a mobile application designed for taxi ride-sharing services. Founded in 2017, the application facilitates instant matching of individuals traveling in the same direction, addressing inefficiencies in transportation and commuting. By enabling users to share taxi rides in real time, NearMe aims to improve the commuting experience and promote a more sustainable community. The platform addresses social inefficiencies by connecting users with similar travel interests, ultimately contributing to a more comfortable and efficient commuting solution.
RT Corporation
Series B in 2019
RT Corporation, based in Chiyoda ku, Japan, develops and sells a range of robots and robotic components, focusing on both military and service applications. Its product lineup includes specialized robots such as army-type models and micro mouse robots, including the CRANE-X7, AI Chip V3, and GAINER mini. The company also offers a variety of services, encompassing robot development, hardware and software creation, compound biopsy services, and contract manufacturing. Established in 2005, RT Corporation aims to meet the growing demands for service robots in various domestic and international markets, leveraging advancements in artificial intelligence to enhance its offerings.
Motion Lib
Venture Round in 2019
Motion Lib, Inc., founded in 2016 and based in Kawasaki, Japan, specializes in haptic technology aimed at enhancing collaboration between humans and robots. The company, originally known as Undou Sekkei Kenkyuusho Limited until its rebranding in April 2017, has developed a specialized chip that estimates and calculates the repulsive force experienced when objects are touched, based on the load force applied to robotic motors. This innovation enables machines to interact more effectively with their environment, expanding their operational capabilities and contributing to increased productivity in various sectors.
GITAI
Series A in 2019
GITAI Inc. is a leading space robotics company based in Tokyo, Japan, established in 2016. The firm specializes in manufacturing humanoid telepresence robots to assist with tasks related to space exploration, particularly within space stations and lunar development. GITAI's product lineup includes the G1 robot, designed for general-purpose automation, the S1 robot for specific task automation, and the H1 manipulation system for remote operation of robots in space. By providing a reliable alternative to human labor, GITAI aims to enhance safety, improve efficiency, and significantly reduce operational costs in space activities. Their technology is intended to facilitate the construction and maintenance of satellites, space stations, and future habitats on the Moon and Mars, ultimately enabling more sustainable and cost-effective space exploration.
Spacely
Series A in 2019
Spacely, Inc. is a cloud software company based in Tokyo, Japan, that specializes in the creation and editing of virtual reality (VR) content. Founded in 2013 and previously known as 3D Stylee until its rebranding in 2018, Spacely offers an intuitive platform that allows users to manage VR web content using photos captured with 360-degree cameras. The software caters to various industries, including real estate, tourism, and retail, enabling businesses to develop their own VR services through an application programming interface (API). By simplifying the VR content creation process, Spacely aims to provide a seamless experience for users looking to engage audiences through immersive digital experiences.
Kyulux
Series B in 2019
Kyulux, Inc. is a Japanese company specializing in the research and development of organic electroluminescent materials for organic light-emitting diode (OLED) displays and lighting solutions. Founded in 2015 and based in Fukuoka, Kyulux is a leader in the advancement of thermally activated delayed fluorescence (TADF) technology, which enhances the efficiency of OLED emission. The company offers innovative products, including its proprietary Hyperfluorescence solution, which combines TADF and fluorescence emitters. This technology enables manufacturers in the display and lighting industries to produce cost-effective, durable, and efficient OLED solutions without relying on rare metals. With a significant intellectual property portfolio developed at Kyushu University and in collaboration with industrial partners, Kyulux is positioned at the forefront of the OLED technology market.
Trajectory
Venture Round in 2019
Trajectory, Ltd. is a Tokyo-based company established in 2018 that specializes in the research and development of control systems for unmanned aerial vehicles (UAVs). The company has created an AI Traffic Control system that facilitates fully autonomous navigation for drones. Its innovative technology allows for the automated generation of flight routes for multiple UAVs, enabling simultaneous deployment and operation. By providing clients with a safe and accessible environment for UAV usage, Trajectory aims to address various operational challenges associated with unmanned aircraft.
meleap
Series B in 2018
Meleap Inc. is a Japanese company based in Minato, established in 2014, that specializes in developing sports gaming platforms using augmented reality (AR) technology. The company is best known for its flagship product, HADO, a new sport in which players wear head-mounted displays and armband sensors to engage in competitive gameplay. In HADO, participants can use virtual "energy balls" and "shields" to score points in a three-on-three format. The immersive experience is designed to provide an innovative and entertaining alternative to traditional sports, showcasing the potential of motion sensors and AR in the gaming industry. Meleap's offerings include various game formats such as monster battle, shooting, kart racing, and play space, catering to a diverse audience seeking engaging and interactive experiences.
Medical Care Service Company
Acquisition in 2018
Medical Care Service Company Inc. is a Japanese firm that specializes in providing comprehensive nursing care services, particularly for the elderly suffering from dementia. Established in 1999 and based in Saitama, the company operates over 210 group homes and seven paid nursing homes, offering a range of services that include assisted living, daily functional training, and in-home care support. Additionally, it provides day care services, nursing support for daily living activities, and sells or rents welfare equipment such as wheelchairs and walking aids. Medical Care Service Company Inc. focuses on enhancing the quality of life for its residents through personalized care and support, while also being involved in personnel recruitment and placement within the healthcare sector.
Alivexis
Series A in 2018
Alivexis is a preclinical stage drug discovery company based in Tokyo, specializing in the rapid design and generation of small molecule clinical candidates aimed at addressing high-value disease targets. The company leverages advanced computational drug discovery techniques and unique biological insights to accelerate the development of new medicines. Its international team consists of experts in drug design and disease biology, drawing on extensive research and development experience from global pharmaceutical and biotechnology firms. Alivexis's platform is designed to enhance biotechnological research, ultimately enabling healthcare professionals to deliver effective treatments to patients with unmet medical needs.
Curadim Pharma
Venture Round in 2018
Curadim Pharma Co., Ltd. is a biotechnology company based in Tokyo, Japan, founded in 2016. The company focuses on the research and development of pharmaceutical products, specifically targeting the discovery of innovative drug candidates that are underutilized. Curadim Pharma aims to create value by advancing these drug candidates through the non-clinical and early clinical development stages. Its research efforts are directed towards addressing diseases with significant unmet medical needs by developing novel drugs originating in Japan. Through its pipeline-driven approach, Curadim Pharma seeks to contribute to the advancement of healthcare by bringing new therapeutic options to market.
TL Genomics
Venture Round in 2018
TL Genomics Co., Ltd., founded in 2015 and based in Tokyo, Japan, specializes in DNA testing services with a focus on prenatal diagnosis. The company has developed a unique technology that isolates fetal nucleated red blood cells from maternal blood, allowing for non-invasive examination of the fetal genome. This innovative approach facilitates early and definitive diagnosis of fetal chromosomal disorders during pregnancy. Additionally, TL Genomics offers laminated microfluidic devices that enhance the efficiency of cell fractionation, thereby supporting healthcare providers in ensuring safe pregnancies for their patients.
Spacely
Seed Round in 2018
Spacely, Inc. is a cloud software company based in Tokyo, Japan, that specializes in the creation and editing of virtual reality (VR) content. Founded in 2013 and previously known as 3D Stylee until its rebranding in 2018, Spacely offers an intuitive platform that allows users to manage VR web content using photos captured with 360-degree cameras. The software caters to various industries, including real estate, tourism, and retail, enabling businesses to develop their own VR services through an application programming interface (API). By simplifying the VR content creation process, Spacely aims to provide a seamless experience for users looking to engage audiences through immersive digital experiences.
Megakaryon
Series C in 2017
Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.
meleap
Series A in 2017
Meleap Inc. is a Japanese company based in Minato, established in 2014, that specializes in developing sports gaming platforms using augmented reality (AR) technology. The company is best known for its flagship product, HADO, a new sport in which players wear head-mounted displays and armband sensors to engage in competitive gameplay. In HADO, participants can use virtual "energy balls" and "shields" to score points in a three-on-three format. The immersive experience is designed to provide an innovative and entertaining alternative to traditional sports, showcasing the potential of motion sensors and AR in the gaming industry. Meleap's offerings include various game formats such as monster battle, shooting, kart racing, and play space, catering to a diverse audience seeking engaging and interactive experiences.
Timers
Venture Round in 2017
Timers Inc., based in Tokyo, Japan, develops a variety of mobile applications aimed at enhancing social connections. The company operates 'Pairy', a social networking service designed specifically for couples, facilitating communication and relationship management. Additionally, Timers offers applications focused on matchmaking for singles, broadening its appeal in the dating landscape. Another aspect of their portfolio includes a family-oriented application that allows users to create and share photos and albums, particularly for child-rearing families. This platform enables families to compile monthly calendars and share memories with friends and relatives, fostering deeper familial connections.
Truss
Venture Round in 2017
Truss is a Tokyo-based company that offers an online platform for comparing building materials, serving the construction industry. The platform provides comprehensive information about various building materials from multiple manufacturers, allowing users to search and compare products based on specific parameters such as performance metrics and required conditions. By consolidating building material data into a user-friendly database, Truss facilitates informed decision-making for all parties involved in construction projects, streamlining the selection and management of materials.
RT Corporation
Series A in 2017
RT Corporation, based in Chiyoda ku, Japan, develops and sells a range of robots and robotic components, focusing on both military and service applications. Its product lineup includes specialized robots such as army-type models and micro mouse robots, including the CRANE-X7, AI Chip V3, and GAINER mini. The company also offers a variety of services, encompassing robot development, hardware and software creation, compound biopsy services, and contract manufacturing. Established in 2005, RT Corporation aims to meet the growing demands for service robots in various domestic and international markets, leveraging advancements in artificial intelligence to enhance its offerings.
Smart Trade
Seed Round in 2017
Smart Trade Inc. is a Tokyo-based technology company that operates a personalized quantitative online investment platform. Founded in 2016, the platform provides a marketplace for investment strategies, allowing users to trade, buy, or rent investment strategies from one another. Its offerings include an advanced artificial intelligence engine, real-time trading capabilities, backtesting tools, and both python and visual coding options. The platform fosters an open community where software developers can upload and sell their investment-related software, enabling investors to benefit from personalized quantitative investment analysis and make informed trading decisions.
ReasonWhy
Venture Round in 2017
ReasonWhy Inc. is a Japan-based company founded on July 7, 2011, that specializes in healthcare IT services. The company offers four main services: Whytlink, a social network designed for doctors; Findme, an online second-opinion service that connects patients with doctors from the Whytlink network; WhytPlot, a big-data analysis tool aimed at pharmaceutical manufacturers in Japan; and yourHospital, a search engine that helps users find specialist hospitals. Through these services, ReasonWhy seeks to enhance communication and information sharing within the medical community while improving patient access to healthcare resources.
Coconala
Venture Round in 2017
Coconala Inc. is an online platform based in Tokyo, Japan, that facilitates the buying and selling of knowledge, skills, and experiences among users. Founded in 2012 and originally known as Wellself until its name change in June 2014, the platform allows individuals to offer a diverse range of services. These services include fortune-telling, mental health support, illustration, design, and consultations related to hobbies and travel. By connecting service providers with those seeking assistance or learning, Coconala fosters a marketplace that caters to various interests and needs.
Magellan Systems Japan
Venture Round in 2017
Magellan Systems Japan, Inc. specializes in the research, development, and licensing of high-precision satellite positioning systems. Founded in 1987 and headquartered in Amagasaki, Japan, the company offers a range of products including software-based global positioning systems (GPS), multi-frequency global navigation satellite systems (GNSS), real-time kinematic systems, and inertial measurement systems. Additionally, it provides GPS timing solutions and autonomous ephemeris prediction services. The company is involved in the import and sale of GNSS-related products, as well as the development of advanced processing technologies. With a focus on delivering accurate location information and time calculations, Magellan Systems Japan plays a significant role in the satellite navigation sector.
Kringle Pharma
Venture Round in 2016
Kringle Pharma, Inc. is a biopharmaceutical company based in Ibaraki, Japan, founded in 2001. The company focuses on the research and development of hepatocyte growth factor (HGF) and its applications in treating various medical conditions. Kringle Pharma's HGF products aim to promote regenerative healing in liver cells and other organs, addressing acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scars. Additionally, the company develops NK4, a bi-functional molecule that serves as an HGF antagonist, inhibiting tumor cell invasion and metastasis while exhibiting antiangiogenic properties. Kringle Pharma's pipeline includes recombinant human HGF for acute renal failure and skin ulcers, as well as NK4-based therapies for cancer treatment.
Karydo Therapeutix
Seed Round in 2016
Karydo Therapeutix, Inc. is a Tokyo-based company that specializes in developing advanced technologies for early disease detection and prevention. Utilizing its iOrgans technology platform, the company focuses on various sub-technologies, including Reverse-iOrgans, Forward-iOrgans, and Drug-iOrgans. These technologies leverage indicators to identify the earliest signs of diseases, anticipate their progression, and assess drug side effects or new applications for existing medications. By employing data science and artificial intelligence, Karydo Therapeutix visualizes the interconnectedness of organs and their functions, creating a digital twin of the body that aids in predicting future health states. Founded in 2015, the company aims to enhance the efficiency of drug development and improve health outcomes through precision research and development.
Kyulux
Series A in 2016
Kyulux, Inc. is a Japanese company specializing in the research and development of organic electroluminescent materials for organic light-emitting diode (OLED) displays and lighting solutions. Founded in 2015 and based in Fukuoka, Kyulux is a leader in the advancement of thermally activated delayed fluorescence (TADF) technology, which enhances the efficiency of OLED emission. The company offers innovative products, including its proprietary Hyperfluorescence solution, which combines TADF and fluorescence emitters. This technology enables manufacturers in the display and lighting industries to produce cost-effective, durable, and efficient OLED solutions without relying on rare metals. With a significant intellectual property portfolio developed at Kyushu University and in collaboration with industrial partners, Kyulux is positioned at the forefront of the OLED technology market.
Normee
Venture Round in 2016
NORMEE Limited specializes in palm recognition technology that allows users to unlock their devices through unique palm patterns, including lines, ridges, veins, and capillaries. Utilizing the built-in camera of smartphones and tablets, NORMEE's system provides accurate authentication using standard visible-spectrum cameras. Founded in February 2005 and based in Tokyo, Japan, the company focuses on developing mobile biometrics technology that supports hybrid biometric authentication tailored to different operating environments. Formerly known as Universal Robot Co., Ltd., NORMEE aims to enhance security and user convenience in mobile device access.
ClipLine
Seed Round in 2016
ClipLine is a provider of a video-based management platform aimed at enhancing organizational execution for businesses with multiple locations in Japan and internationally. Launched in October 2014, the service initially focused on the restaurant industry but has since expanded to various sectors, including nursing care, retail, transportation, and manufacturing. The platform facilitates digital transformation by improving organizational structure and communication, allowing clients to monitor quality and enhance sales effectively. Currently, ClipLine serves around 15,000 locations and approximately 420,000 users, demonstrating its widespread adoption across diverse fields.
On-Chip Biotechnologies
Venture Round in 2015
On-Chip Biotechnologies Co., Ltd. is a Tokyo-based company specializing in the development and manufacturing of advanced biosafety flow cytometers and related medical devices. Founded in 2005, the company offers innovative products such as the FISHMAN-R analyzer, which utilizes a microfluidics chip for flow cytometry. This analyzer is capable of detecting and analyzing specific bacteria and cells through the Flow-FISH method, accommodating particles ranging from 0.5μm to 20μm in size and allowing for analysis of small sample quantities. In addition to flow cytometry, On-Chip Biotechnologies produces cell sorters and droplet generators. Their cell sorting device is designed to provide damage-free and contamination-free cell separation by employing a liquid transfer system on a disposable microchannel chip, thus reducing sorter-induced cellular stress.
Research and Innovation
Venture Round in 2015
Research and Innovation Co., Ltd. is a market research company based in Tokyo, Japan, established in 2011. It specializes in providing marketing research, sales promotion, and information services through the Internet. The company offers a range of services, including barcode research and promotion, brand image association surveys, and investigations into consumer interests. It conducts in-store and street surveys targeting foreign tourists in Japan and serves a diverse clientele across various sectors, including food, beauty, retail, finance, and media. Additionally, Research and Innovation develops tools that analyze consumer purchasing behavior, helping businesses gain insights into promotional effectiveness and market trends, thereby facilitating revenue growth and strategic decision-making.
A-Traction
Seed Round in 2015
A-Traction Inc., founded in 2015 and based in Kashiwa, Japan, specializes in the development of surgical robots designed to enhance laparoscopic surgery. The company focuses on creating medical devices that act as collaborative partners for surgeons during operations, promoting safer and more effective surgical procedures. A-Traction's innovative concept, known as ANSUR, allows the robotic system to assist surgeons by moving in tandem with their actions, thereby improving the overall surgical experience. The company's mission is to commercialize advanced surgery support robots that leverage their lightweight design to provide high-quality surgical outcomes for a greater number of patients.
SmileWorks
Venture Round in 2015
SmileWorks Inc. is a company that specializes in designing and developing cloud-based and web-based application services tailored for ministries and small to midsize businesses (SMBs). Founded in 2003 and headquartered in Hirata, Shimane, Japan, the company offers an integrated ERP system that streamlines back-office operations. Its software includes features for sales management, purchasing management, project income and expenditure oversight, inventory management, financial accounting, payroll processing, and expense settlement. Additionally, it facilitates automatic payment reconciliation and cash flow management through API integration with banks. SmileWorks also provides accounts receivable liquidation services, helping clients enhance their productivity and operational efficiency.
Gengo
Series C in 2015
Gengo, Inc. operates a professional human translation platform that connects individuals and businesses with a community of over 18,000 qualified translators from 114 countries, covering 37 languages and 64 language pairs. Founded in 2008 and headquartered in Tokyo, Japan, with an additional office in Silicon Valley, Gengo provides its services through an accessible website and API, allowing clients to order translations for various types of content. The platform is designed to deliver higher quality translations compared to machine translation and offers faster turnaround times than traditional providers. Gengo serves a diverse range of industries, including e-commerce, travel, and media, helping companies publish content such as product descriptions and user reviews in multiple languages. The company has collaborated with notable clients, including JTB, TripAdvisor, BuzzFeed, and Rakuten. As of December 31, 2018, Gengo operates as a subsidiary of Lionbridge Technologies, Inc.
Gengo
Series C in 2015
Gengo, Inc. operates a professional human translation platform that connects individuals and businesses with a community of over 18,000 qualified translators from 114 countries, covering 37 languages and 64 language pairs. Founded in 2008 and headquartered in Tokyo, Japan, with an additional office in Silicon Valley, Gengo provides its services through an accessible website and API, allowing clients to order translations for various types of content. The platform is designed to deliver higher quality translations compared to machine translation and offers faster turnaround times than traditional providers. Gengo serves a diverse range of industries, including e-commerce, travel, and media, helping companies publish content such as product descriptions and user reviews in multiple languages. The company has collaborated with notable clients, including JTB, TripAdvisor, BuzzFeed, and Rakuten. As of December 31, 2018, Gengo operates as a subsidiary of Lionbridge Technologies, Inc.
Megakaryon
Series B in 2015
Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.
Cyfuse Biomedical
Venture Round in 2015
Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.
Lacras
Venture Round in 2014
Lacras Corporation, founded in 2005 and based in Tokyo, Japan, specializes in human resource management solutions. The company offers web-based HR cloud services and business process outsourcing (BPO) services that assist organizations in optimizing their HR operations. Lacras provides a comprehensive personnel database that facilitates the management of employee information, talent management functions, and the integration of data with clients' systems. This enables businesses to efficiently collect and manage personnel information, thereby streamlining their HR processes and improving overall operational effectiveness.
Jtower
Venture Round in 2014
JTOWER Inc. is a telecommunications infrastructure company based in Tokyo, Japan, specializing in infrastructure sharing services. Founded in 2012, the company focuses on the design and construction of information communication infrastructure, as well as the development of communication-related solutions. JTOWER provides a range of services that include in-building infrastructure sharing, cloud-managed Wi-Fi, outdoor tower sharing, and local 5G services, catering primarily to landlords and mobile network operators. Additionally, it offers site locator systems to facilitate the deployment of mobile infrastructure. As a subsidiary of Nippon Telegraph and Telephone Corporation, JTOWER plays a vital role in enhancing telecommunications infrastructure across Japan.
Research and Innovation
Venture Round in 2014
Research and Innovation Co., Ltd. is a market research company based in Tokyo, Japan, established in 2011. It specializes in providing marketing research, sales promotion, and information services through the Internet. The company offers a range of services, including barcode research and promotion, brand image association surveys, and investigations into consumer interests. It conducts in-store and street surveys targeting foreign tourists in Japan and serves a diverse clientele across various sectors, including food, beauty, retail, finance, and media. Additionally, Research and Innovation develops tools that analyze consumer purchasing behavior, helping businesses gain insights into promotional effectiveness and market trends, thereby facilitating revenue growth and strategic decision-making.
Looop
Seed Round in 2014
Looop Inc. is a renewable energy company based in Tokyo, Japan, specializing in the construction, development, and maintenance of solar power generation systems. Founded in 2011, Looop provides services that encompass the entire value chain, including the development, sales, and operation of photovoltaic power stations. By owning and managing the processes involved in solar energy production, the company aims to lower costs and promote sustainable living. Looop's offerings facilitate a seamless transition for customers looking to adopt renewable energy solutions, thereby contributing to the growth of the solar energy sector.
gumi
Series H in 2014
gumi Inc. is a Japan-based entertainment company that specializes in developing, operating, and distributing online games for mobile devices. Founded in 2007 by CEO Hironao Kunimitsu, gumi has expanded its presence internationally, with multiple subsidiaries across Asia, Europe, and North America. The company provides a diverse range of services, including native application development, browser-based gaming, and game localization for third-party content. In addition to its core gaming business, gumi is actively involved in the blockchain sector and explores emerging technologies within the XR space, encompassing virtual, augmented, and mixed reality. Headquartered in Tokyo, gumi aims to deliver engaging gaming experiences while maintaining a creative and passionate approach to content development.
GlyTech
Series A in 2014
GlyTech, Inc. specializes in the production of human-type N-glycans and the development of glycosylation technologies, including glycopeptide and glycoprotein synthesis. Founded in 2012 and based in Kyoto, Japan, the company focuses on enhancing the development of biopharmaceuticals and oligonucleotide therapeutics through innovative glycan production techniques. GlyTech offers a range of services, including custom synthesis, contract research and development, and the licensing of glycosylated peptides and proteins. Additionally, the company supplies standard reagents, supporting researchers in their efforts to advance human health by expanding their capabilities in glycoscience research and biotherapeutic analysis.
Streetmedia
Venture Round in 2013
Streetmedia, Inc. is a media services provider based in Tokyo, Japan, specializing in commercial areas. Founded in 2008, the company focuses on delivering a range of services including shopping media and area casting. Its platform is designed to offer up-to-date information on street media, enabling clients to access valuable insights related to local media business and business development trends globally. Through its innovative approach, Streetmedia aims to enhance the effectiveness of media strategies for various commercial entities.
gumi
Series G in 2013
gumi Inc. is a Japan-based entertainment company that specializes in developing, operating, and distributing online games for mobile devices. Founded in 2007 by CEO Hironao Kunimitsu, gumi has expanded its presence internationally, with multiple subsidiaries across Asia, Europe, and North America. The company provides a diverse range of services, including native application development, browser-based gaming, and game localization for third-party content. In addition to its core gaming business, gumi is actively involved in the blockchain sector and explores emerging technologies within the XR space, encompassing virtual, augmented, and mixed reality. Headquartered in Tokyo, gumi aims to deliver engaging gaming experiences while maintaining a creative and passionate approach to content development.
CMerTV Japan
Venture Round in 2013
CMer TV provides video adverts to each and every location via its own private network and enables video branding. It interacts with platforms and media in a variety of real-world contexts. They offer a platform for video advertising that works online and offline.
Capable
Seed Round in 2013
Capable Co., Ltd., established on July 13, 2012, in Kyoto, Japan, is an engineering firm that specializes in manufacturing metal molds for semiconductor sealing and providing comprehensive molding solutions. The company focuses on revolutionizing precision mold chase technology through its innovative mold production systems. Capable's offerings include the fabrication, inspection, and assembly of mold parts, which are then completed as mold chases. These chases are accompanied by light-emitting diodes and electronic components, allowing clients to obtain customized solutions at competitive prices.
Siglead
Venture Round in 2013
Siglead Inc. is a company based in Yokohama, Japan, founded in 2007, specializing in the research and development of signal processing algorithms and related technologies. The company focuses on creating signal processing LSI (large scale integration) units and intellectual property, particularly for solid-state drives (SSDs). Siglead is known for its development of error correction methods for SSDs and NAND flash memory, as well as the design of SSD controller LSI, which enhances the reliability and performance of these storage solutions. Their product offerings include the SigNAS series of NAND flash memory testers, which incorporate advanced evaluation and error analysis technologies. These products are tailored to meet user needs and support a broad range of NAND flash generations, ultimately aiming to improve the efficiency of product cycles associated with NAND flash memory.
PRISM Pharma
Series C in 2013
PRISM Pharma develops and provides biotechnology solutions for medical oncology. It researches on small molecule technologies that offers drug discovery services. PRISM Pharma is based in Yokohama, Japan.
Marketing Applications
Venture Round in 2012
Marketing Applications, Inc. specializes in providing comprehensive online research solutions with a focus on market research and consumer insights. Founded in 2006 and headquartered in Tokyo, Japan, the company operates additional facilities in Singapore. It offers a robust platform that includes cloud-based survey systems, consumer panels, and data aggregation tools, catering to a diverse clientele, such as market research firms, media agencies, manufacturers, and public sector organizations. The company is recognized as a leading research platform in Japan, utilized by over 200 companies for conducting surveys and analyzing data. Its services encompass various research domains, including consumer behavior, product evaluation, and fast-moving consumer goods (FMCG) analysis, thereby enabling businesses to gain critical insights and make informed decisions.
Octoba
Venture Round in 2012
Octoba Inc. is a Tokyo-based company founded in June 2004, specializing in the planning, development, and operation of smartphone applications. With a strong media presence since 2009, Octoba has introduced tens of thousands of applications through its platform, which includes an online review site that provides essential information for Android users. This platform facilitates the discovery and usage of various applications, enhancing the experience for users seeking mobile solutions.
gumi
Series F in 2011
gumi Inc. is a Japan-based entertainment company that specializes in developing, operating, and distributing online games for mobile devices. Founded in 2007 by CEO Hironao Kunimitsu, gumi has expanded its presence internationally, with multiple subsidiaries across Asia, Europe, and North America. The company provides a diverse range of services, including native application development, browser-based gaming, and game localization for third-party content. In addition to its core gaming business, gumi is actively involved in the blockchain sector and explores emerging technologies within the XR space, encompassing virtual, augmented, and mixed reality. Headquartered in Tokyo, gumi aims to deliver engaging gaming experiences while maintaining a creative and passionate approach to content development.
Tella
Venture Round in 2011
Tella, Inc. is a biotechnology company based in Tokyo, Japan, specializing in the research and development of regenerative and cell medicines, particularly dendritic cell vaccine therapy for cancer treatment. The company collaborates with affiliated medical institutions, offering techniques and operational expertise in dendritic cell vaccine therapy. Tella provides comprehensive consultation services that include the establishment and maintenance of cell processing centers, management systems for cell cultivation, and training for cell cultivation technicians. Additionally, the company supports contract medical institutions by offering training on treatment practices, documentation for therapy assessment, and information services for both physicians and patients. Founded in 2004, Tella aims to maximize immune responses in cancer therapies through its innovative approaches and support services.
Berg Earth
Venture Round in 2010
Berg Earth Co Ltd is a Japan-based agribusiness company specializing in the production and sale of vegetable seedlings. The company primarily focuses on grafted seedlings of various fruits and vegetables, catering to the agricultural needs of its clientele. In addition to its seedling offerings, Berg Earth engages in the purchase and sale of agricultural products and materials, contributing to the broader agricultural supply chain. Its diverse product range includes various types of seedlings designed to meet different farming requirements.
Full Speed
Post in 2010
Full Speed Inc. is a Tokyo-based company specializing in internet marketing support services in Japan. Founded in 2001, it offers a comprehensive range of services, including search engine optimization (SEO), listing and affiliate advertising, display advertising, and social media advertising. The company operates through several segments: the Internet Advertising Agency segment focuses on listing advertising and search engine marketing, while the Ad Network segment provides integrated advertising network services. Additionally, Full Speed's Information Media segment is involved in the planning and creation of information sites and e-commerce platforms. The Creative segment offers website and banner creation services. The company also provides consulting services in SEO, social media operations, web architecture, and advertisement effect measurement, along with specialized services in healthcare marketing. Full Speed Inc. is a subsidiary of FreeBit Co., Ltd.
KnowledgeSuite
Venture Round in 2010
KnowledgeSuite is a Tokyo-based company specializing in the development of SaaS business applications in Japan. Established in 2006, KnowledgeSuite is a subsidiary of KDDI Corporation.
MonotaRO
Post in 2010
MonotaRO Co., Ltd. is a Japanese e-commerce company that specializes in the sale of maintenance, repair, and operations (MRO) products. Established in 2000 and headquartered in Amagasaki, Japan, the company serves a wide range of industries, including manufacturing, construction, and automotive, through its online platform. MonotaRO operates not only in Japan but also in Korea, China, Indonesia, and other international markets. Originally known as Sumisho Grainger Co., Ltd., the company rebranded in February 2006 to better reflect its focus on industrial supply products.
Aisei Pharmacy
Seed Round in 2010
Aisei Pharmacy is a retail pharmacy chain based in Marunouchi Chiyoda-ku, Tokyo, Japan, founded in September 1984. The company specializes in the sale of prescription drugs, proprietary medications, and non-prescription medicines through a network of over 350 dispensing pharmacies across the country. In addition to its pharmacy operations, Aisei Pharmacy operates dispensary clinics that offer nursing care and medications for patients, as well as preventive health check-ups for healthy individuals. This comprehensive approach enables Aisei Pharmacy to support both the treatment of illnesses and the promotion of overall health and wellness.
All Ads
Venture Round in 2008
All Ads is a Tokyo-based company that specializes in digital marketing services aimed at enhancing the cost-effectiveness of advertising for business professionals. By focusing on LTV marketing, All Ads combines data, technology, and consulting to optimize advertising strategies. The company provides a range of services including in-house media management, affiliate advertising consulting, operational advertising consulting, and roundtable discussions. Through its comprehensive approach, All Ads seeks to support the growth of its clients' businesses by improving their advertising performance.
Emergency Assistance Japan
Venture Round in 2007
Emergency Assistance Japan Co., Ltd., founded in 2003 and headquartered in Tokyo, offers a range of medical and lifestyle assistance services both within Japan and internationally. The company specializes in medical and security assistance programs, including support for overseas students and lifestyle services. It also provides emergency response services and assistance tailored for foreign nationals. By focusing on comprehensive risk management and coordination, Emergency Assistance Japan aims to ensure the safety and well-being of individuals while traveling or residing abroad.
Cyberdyne
Seed Round in 2007
Cyberdyne Inc. is a Japanese company founded by Dr. Yoshiyuki Sankai from the University of Tsukuba, focusing on the research and development of advanced medical welfare equipment and systems. The company aims to enhance human capabilities through its innovative Robot Suit HAL®, which is designed for various applications including rehabilitation support, assistance for the elderly and disabled, disaster rescue, entertainment, and heavy labor tasks. Cyberdyne's product offerings include the Hybrid Assistive Limb (HAL) for lower limbs and single joints, along with lumbar support, a Table Interface, and cleaning robots. Additionally, the company provides services such as HAL therapy in the medical sector and non-medical services like HAL fit and Robo care, all contributing to improved quality of life and support in various fields.
SymBio Pharmaceuticals
Seed Round in 2005
SymBio Pharmaceuticals Limited is a biopharmaceutical company based in Tokyo, Japan, focused on the research, development, manufacturing, and marketing of pharmaceutical drugs, primarily in the fields of oncology and hematology. The company develops various anti-cancer agents, including Treakisym, which is used to treat non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia, and is currently undergoing Phase III trials for relapsed/refractory diffuse large B-cell lymphoma. Additionally, SymBio is working on several other drug formulations, including SyB L-1701, SyB L-1702, and Rigosertib SyB-C-0501, as well as SyB L-1101 and SyB C-1101 for higher-risk myelodysplastic syndromes. The company also has a candidate, SyB V-1901, aimed at treating infectious diseases. SymBio Pharmaceuticals operates primarily in Japan, South Korea, China, Hong Kong, Taiwan, and Singapore.
Gene Techno Science
Seed Round in 2004
Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan. The company develops drugs for the treatment of immunological, cardiovascular, ophthalmic, infectious, and renal diseases as well as oncology drugs. It also offers Filgrastim for the treatment of cancer. Gene Techno Science was founded in 2001 and is headquartered in Sapporo, Japan.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.